Role of Vitamin D in the Pathophysiology and Treatment of Type 2 Diabetes

Author(s): Erica Stivelman, Ravi Retnakaran

Journal Name: Current Diabetes Reviews

Volume 8 , Issue 1 , 2012

Become EABM
Become Reviewer
Call for Editor


The secosteroid vitamin D is best known for its role in calcium regulation and bone metabolism. Recently, however, an emerging body of evidence has suggested that vitamin D may have previously-unrecognized effects on a variety of physiologic processes, including those relating to glucose homeostasis. Indeed, vitamin D insufficiency has been linked with type 2 diabetes (T2DM). In this review, the potential association between vitamin D and T2DM will be evaluated from both a pathophysiologic and clinical perspective. We consider the biologic evidence in support of a mechanistic contribution of vitamin D insufficiency to insulin resistance and beta-cell dysfunction, the two main pathophysiologic defects underlying T2DM. We also evaluate the clinical data linking vitamin D with these metabolic defects and dysglycemia. Finally, interventional studies addressing the effect of vitamin D supplementation on glucose homeostasis are considered. At present, this evolving literature is marked by many conflicting results and methodologic limitations, such that definitive conclusion on the role of vitamin D in T2DM remains elusive. Nevertheless, in light of the widespread prevalence of both vitamin D insufficiency and T2DM, this potential relationship could hold enormous public health implications and hence demands further study to address its unresolved questions.

Keywords: Vitamin D, type 2 diabetes, insulin resistance, beta-cell dysfunction, Pathophysiology, Glucose Metabolism, cancers, multiple sclerosis, rheumatoid arthritis, type 1 diabetes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 01 March, 2012
Page: [42 - 47]
Pages: 6
DOI: 10.2174/157339912798829179

Article Metrics

PDF: 52